Skip to main content
Clinical Trials/NCT06759389
NCT06759389
Recruiting
N/A

The VENTOR Clinical Study - VENTilation and Airway Optimization for Cardiac Arrest Resuscitation

CoLabs Medical1 site in 1 country25 target enrollmentApril 4, 2025

Overview

Phase
N/A
Intervention
Not specified
Conditions
Cardiac Arrest (CA)
Sponsor
CoLabs Medical
Enrollment
25
Locations
1
Primary Endpoint
Ability to provide oxygenation during CPR
Status
Recruiting
Last Updated
10 months ago

Overview

Brief Summary

To evaluate the initial safety and effectiveness of the Ventor Airway System in providing short-term ventilation support in non-breathing subjects during cardiopulmonary resuscitation (CPR) and respiratory arrests.

Registry
clinicaltrials.gov
Start Date
April 4, 2025
End Date
June 2026
Last Updated
10 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
CoLabs Medical
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adults aged 18-75 years, inclusive
  • IHCA (non-traumatic)
  • At least 4 feet in height

Exclusion Criteria

  • Intubated with an endotracheal tube (ET)
  • Valid do-not-attempt-resuscitation (DNAR) or study opt-out bracelet (including previous enrollment bracelet)
  • LAR or Family member objects to enrollment
  • Obvious signs of irreversible death (rigor mortis, dependent lividity, decapitation, transection, decomposition)
  • Responsive with an intact gag reflex
  • Blunt, penetrating, or burn-related injury, drowning, or electrocution
  • Known upper airway foreign body or mass
  • Lower airway obstruction
  • Dental gap of \< 2 cm
  • Ingested caustic substances

Outcomes

Primary Outcomes

Ability to provide oxygenation during CPR

Time Frame: From device insertion through 1 hour

As measured through the monitoring of intra-arrest cerebral oximetry

Ability to provide ventilation during CPR

Time Frame: From device insertion through 1 hour

As measured through the monitoring of intra-arrest PaCO2

Number of participants with device-related adverse events

Time Frame: From device insertion through 3 months

Number and rate of adverse events

Study Sites (1)

Loading locations...

Similar Trials